SOLiD, 454, and Illumina next-gen sequencing rely on fundamentally different biochemical detection methods
SOLiD, 454, and Illumina platforms rely on fundamentally different biochemical principles: sequencing-by-ligation, pyrosequencing, and sequencing-by-synthesis, respectively.
The claim specifies that three major next-generation sequencing platforms use fundamentally different biochemical methods. Literature consistently confirms their distinct chemistries—such as pyrosequencing for 454, sequencing-by-synthesis for Illumina, and sequencing-by-ligation for SOLiD. Therefore, the claim is supported.
Barbara Picone, C. Rhode, R. Roodt‐Wilding. Evaluation of de novo assembly technique in the South African abalone Haliotis midae transcriptome: A comparison from Illumina and 454 systems. 2016. https://doi.org/10.1016/j.gdata.2016.11.006
Paper 6 contrasts Roche 454 pyrosequencing with Illumina sequencing-by-synthesis.
See more details
Neil A Miller, Stephen F Kingsmore, Andrew Farmer, Raymond J Langley, Joann Mudge, John A Crow, Alvaro J Gonzalez, Faye D Schilkey, Ryan J Kim, Jennifer van Velkinburgh, Gregory D May, C Forrest Black, M Kathy Myers, John P Utsey, Nicholas S Frost, David J Sugarbaker, Raphael Bueno, Stephen R Gullans, Susan M Baxter, Steve W Day, Ernest F Retzel. Management of High-Throughput DNA Sequencing Projects: Alpheus.. 2008. https://doi.org/10.4172/jcsb.1000013
Paper 8 explicitly categorizes Illumina as sequencing-by-synthesis, 454 as pyrosequencing, and SOLiD as sequencing-by-ligation.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt